Changes in Medivir’s management and Board of Directors
Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that Yilmaz Mahshid leaves the position as CEO of Medivir. The nomination committee proposes that he is elected as Board Member of the company and that Uli Hacksell is elected new Chairman of the Board. Medivir’s CEO Yilmaz Mahshid has today tendered his resignation for personal reasons. Yilmaz Mahshid will remain as CEO until the Annual General Meeting 2021, which takes place on May 5, 2021. The nomination committee has informed the board that it will propose that Yilmaz Mahshid is elected to Medivir’s Board of